We found that shRNA mediated B4GALT7 suppression suppressed the migrative and invasive abilities of HCC cells, whereas miR-338-3p inhibitor significantly rescued these phenotypes (Figs. 7A–7B). This evidence concerns the gene B4GALT7 and hepatocellular carcinoma.